Man Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Man Jin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Chenyang Gao
Department of Neurology, Hebei General Hospital, Shijiazhuang, China
2 shared publications - Xueru Zhang
Department of Neurology, Hebei General Hospital, Shijiazhuang, China
2 shared publications - Aihua Ni
Department of Neurology, Hebei General Hospital, Shijiazhuang, China
1 shared publication - Di Fei
Department of Neurology, Hebei General Hospital, Shijiazhuang, China
1 shared publication - Hao Liang
Cardiology Department, Hebei General Hospital, Shijiazhuang, China
1 shared publication - Litao Li
Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China
1 shared publication
Latest Publications
- Open Access
- 28 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (48) , e46196
Correlation between plasma cortisol and white matter hyperintensity in middle-aged and elderly individuals with major depressive disorder: A cross-sectional study
To examine the relationship between plasma cortisol levels and the severity of white matter hyperintensities (WMH) in patients with major depressive disorder (MDD). This study included 240 patients with MDD who were hospitalized in the Department of Neuropsychology at Hebei General Hospital from January 1, 2023, to December 31, 2024. General data and plasma cortisol concentrations were obtained. Based on the total score of the Fazekas scale, patients were divided into 3 groups: no/mild group (Fazekas scale total score 0–2 points, 87 participants), moderate group (Fazekas scale total score 3–4 points, 85 participants), and severe group (Fazekas scale total score 5–6 points, 68 participants). The disparities in general and clinical data among various patient groups were compared, and the risk factors for WMH were investigated. Among 3 groups of patients, significant differences were in terms of age (58.23 ± 8.64 vs 63.59 ± 7.62 vs 67.51 ± 7.78), proportion of hypertension (37.90% vs 42.40% vs 67.60%), total cholesterol (4.85 ± 1.06 vs 4.95 ± 1.12 vs 4.53 ± 1.05), low-density lipoprotein (3.00 ± 0.70 vs 3.10 ± 0.81 vs 2.67 ± 0.79), and plasma cortisol level (13.25 ± 4.31 vs 14.36 ± 4.51 vs 15.86 ± 5.06). Age (odds ratio [OR] = 1.10, P = .00), hypertension (OR = 1.54, P = .03), and cortisol level (OR = 1.09, P = .00) were independent risk variables for the severity of WMH in individuals with MDD, while low-density lipoprotein (OR = 0.30, P = .04) was a protective factor for the severity of white matter hyperintensity in patients with depression. Plasma cortisol is proposed as an independent risk factor influencing the severity of white matter hyperintensity in individuals with MDD, and ameliorating elevated cortisol levels in these patients may enhance their prognosis.
- 28 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (48) , e46196
Open AccessCorrelation between plasma cortisol and white matter hyperintensity in middle-aged and elderly individuals with major depressive disorder: A cross-sectional study
To examine the relationship between plasma cortisol levels and the severity of white matter hyperintensities (WMH) in patients with major depressive disorder (MDD). This study included 240 patients with MDD who were hospitalized in the Department of Neuropsychology at Hebei General Hospital from January 1, 2023, to December 31, 2024. General data and plasma cortisol concentrations were obtained. Based on the total score of the Fazekas scale, patients were divided into 3 groups: no/mild group (Fazekas scale total score 0–2 points, 87 participants), moderate group (Fazekas scale total score 3–4 points, 85 participants), and severe group (Fazekas scale total score 5–6 points, 68 participants). The disparities in general and clinical data among various patient groups were compared, and the risk factors for WMH were investigated. Among 3 groups of patients, significant differences were in terms of age (58.23 ± 8.64 vs 63.59 ± 7.62 vs 67.51 ± 7.78), proportion of hypertension (37.90% vs 42.40% vs 67.60%), total cholesterol (4.85 ± 1.06 vs 4.95 ± 1.12 vs 4.53 ± 1.05), low-density lipoprotein (3.00 ± 0.70 vs 3.10 ± 0.81 vs 2.67 ± 0.79), and plasma cortisol level (13.25 ± 4.31 vs 14.36 ± 4.51 vs 15.86 ± 5.06). Age (odds ratio [OR] = 1.10, P = .00), hypertension (OR = 1.54, P = .03), and cortisol level (OR = 1.09, P = .00) were independent risk variables for the severity of WMH in individuals with MDD, while low-density lipoprotein (OR = 0.30, P = .04) was a protective factor for the severity of white matter hyperintensity in patients with depression. Plasma cortisol is proposed as an independent risk factor influencing the severity of white matter hyperintensity in individuals with MDD, and ameliorating elevated cortisol levels in these patients may enhance their prognosis.
- Open Access
- 16 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (24) , e34058
Association of triglyceride-glucose index with major depressive disorder: A cross-sectional study
The triglyceride-glucose (TyG) index has been proposed as a new marker for insulin resistance, which is associated with a risk of major depressive disorder (MDD). This study aims to explore whether the TyG index is correlated with MDD. In total, 321 patients with MDD and 325 non-MDD patients were included in the study. The presence of MDD was identified by trained clinical psychiatrists using the International Classification of Diseases 10th Revision. The TyG index was calculated as follows: Ln (fasting triglyceride [mg/dL] × fasting glucose [mg/dL]/2). The results revealed that the MDD group presented higher TyG index values than the non-MDD group (8.77 [8.34–9.17] vs 8.62 [8.18–9.01], P < .001). We also found significantly higher morbidity of MDD in the highest TyG index group than in the lower TyG index group (59.9% vs 41.4%, P < .001). Binary logistic regression revealed that TyG was an independent risk factor for MDD (odds ratio [OR] 1.750, 95% confidence interval: 1.284–2.384, P < .001). We further assessed the effect of TyG on depression in sex subgroups. The OR was 3.872 (OR 2.014, 95% confidence interval: 1.282–3.164, P = .002) for the subgroup of men. It is suggested that the TyG index could be closely associated with morbidity in MDD patients; thus, it may be a valuable marker for identifying MDD.
- 16 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (24) , e34058
Open AccessAssociation of triglyceride-glucose index with major depressive disorder: A cross-sectional study
The triglyceride-glucose (TyG) index has been proposed as a new marker for insulin resistance, which is associated with a risk of major depressive disorder (MDD). This study aims to explore whether the TyG index is correlated with MDD. In total, 321 patients with MDD and 325 non-MDD patients were included in the study. The presence of MDD was identified by trained clinical psychiatrists using the International Classification of Diseases 10th Revision. The TyG index was calculated as follows: Ln (fasting triglyceride [mg/dL] × fasting glucose [mg/dL]/2). The results revealed that the MDD group presented higher TyG index values than the non-MDD group (8.77 [8.34–9.17] vs 8.62 [8.18–9.01], P < .001). We also found significantly higher morbidity of MDD in the highest TyG index group than in the lower TyG index group (59.9% vs 41.4%, P < .001). Binary logistic regression revealed that TyG was an independent risk factor for MDD (odds ratio [OR] 1.750, 95% confidence interval: 1.284–2.384, P < .001). We further assessed the effect of TyG on depression in sex subgroups. The OR was 3.872 (OR 2.014, 95% confidence interval: 1.282–3.164, P = .002) for the subgroup of men. It is suggested that the TyG index could be closely associated with morbidity in MDD patients; thus, it may be a valuable marker for identifying MDD.